Article Details

Reducing Dose of Belimumab in Patients with Lupus - HCPLive

Retrieved on: 2024-06-19 22:03:02

Tags for this article:

Click the tags to see associated articles and topics

Reducing Dose of Belimumab in Patients with Lupus - HCPLive. View article details on hiswai:

Excerpt

Belimumab is an anti-B-cell activating factor (BAFF) monoclonal antibody and biologic therapy commonly used in the treatment of systemic lupus ...

Article found on: www.hcplive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo